APA (7th ed.) Citation

Colomb, A., Allignet, B., Lamkhioued, M., Swalduz, A., Falchero, L., Kienlen, A., . . . Moncharmont, C. (2024). Prognostic value of neutrophil to lymphocyte ratio and lymphocyte counts before durvalumab consolidation after radio-chemotherapy in locally advanced non-small cell lung cancer. Radiation Oncology, 19(1), 1. https://doi.org/10.1186/s13014-024-02553-z

Chicago Style (17th ed.) Citation

Colomb, Arnaud, Benoit Allignet, Mehdi Lamkhioued, Aurelie Swalduz, Lionel Falchero, Aurélie Kienlen, Michaël Duruisseaux, and Coralie Moncharmont. "Prognostic Value of Neutrophil to Lymphocyte Ratio and Lymphocyte Counts Before Durvalumab Consolidation After Radio-chemotherapy in Locally Advanced Non-small Cell Lung Cancer." Radiation Oncology 19, no. 1 (2024): 1. https://doi.org/10.1186/s13014-024-02553-z.

MLA (9th ed.) Citation

Colomb, Arnaud, et al. "Prognostic Value of Neutrophil to Lymphocyte Ratio and Lymphocyte Counts Before Durvalumab Consolidation After Radio-chemotherapy in Locally Advanced Non-small Cell Lung Cancer." Radiation Oncology, vol. 19, no. 1, 2024, p. 1, https://doi.org/10.1186/s13014-024-02553-z.